Catherine Uyttenhove

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

Catherine Uyttenhove, Luc Pilotte, Ivan Théate et al. · Nature Medicine · 2003 · 2.3K citations

Inflammation, Cancer Immunosurveillance, Biochemistry +8

Transforming growth factor-β 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9–producing subset

Marc Veldhoen, Catherine Uyttenhove, Jacques Van Snick et al. · Nature Immunology · 2008 · 1.2K citations

Interleukin 9–Producing, Growth Factor-β 'Reprograms, Lymphocyte Development +10

Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas.

Jacques Van Snick, Sylvie Cayphas, Anne Vink et al. · Proceedings of the National Academy of Sciences · 1986 · 685 citations · Full text

Lymphoid Neoplasia, B-cell Hybridomas, Growth Factor Activity +14

Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase

Luc Pilotte, Pierre Larrieu, Vincent Stroobant et al. · Proceedings of the National Academy of Sciences · 2012 · 564 citations · Full text

Immunotoxicology, Immunology, Immunoediting +18

Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice

David Bending, Hugo De La Peña, Marc Veldhoen et al. · Journal of Clinical Investigation · 2009 · 541 citations · Full text

T-regulatory Cell, Immunology, Immune Regulation +23